Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists test 'Supercharged' immune cells to fight childhood cancer

NCT ID NCT00085930

Summary

This study tested a new treatment for children with high-risk neuroblastoma, a type of cancer. Researchers took a patient's own immune cells, modified them in a lab to better recognize and attack cancer cells, and then gave them back to the patient. The main goals were to check if this treatment was safe and to see if these modified cells could survive longer in the body to fight the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Texas Children's Hospital

    Houston, Texas, 77030, United States

Conditions

Explore the condition pages connected to this study.